baber/WOPTO huggingface dataset:
Patent FI-963013-A0 (FI)
Inventor: KJAER OLE
IPC: F16K1/52
Filed: 1996-07-30
Abstract: In a radiator valve a second throttle point which is formed by a gap (119) between an annular face (114) surrounding the valve seat and the end face of an insert (113) is located downstream of a first throttle point between the valve seat (108) and the closure member (109). The gap (119) is axially offset with respect to the valve seat (108). In particular, the valve seat (108) projects beyong the annular face (114). In this manner, valve noise can be considerably reduced.
Patent FI-964054-A0 (FI)
Inventor: DIAZ STEPHEN
IPC: H05K5/00
Filed: 1996-10-10
Abstract: An environmentally sealed electronics assembly. The assembly includes a flexible envelope surrounding the active electronics board. The electronics board is insertable into the envelope and with subsequent sealing provides a reenterable but environmentally sealed active electronics package. Methods of manufacturing the assembly are also described.
Patent FI-970694-A0 (FI)
Inventor: WATTS PETER JAMES
IPC: A61K9/00
Filed: 1997-02-19
Abstract: PCT No. PCT/GB95/01980 Sec. 371 Date Apr. 21, 1997 Sec. 102(e) Date Apr. 21, 1997 PCT Filed Aug. 21, 1995 PCT Pub. No. WO96/05810 PCT Pub. Date Feb. 29, 1996A drug delivery composition for administration to mucosa is provided. The composition includes a pharmacologically active compound and particles, preferably powder or microspheres, of chitosan or a chitosan derivative or salt wherein the particles are either solidified or partially cross-linked such that they have a zeta potential of +0.5 to +50 mV. Solidified particles are made by treating particles made from a water soluble chitosan salt with an alkaline agent such as sodium hydroxide in a non-acid containing water to render them insoluble.
Patent FI-980112-A0 (FI)
Inventor: LEE BYUNG H
IPC: C07D491/22
Filed: 1998-01-20
Abstract: The present invention includes various substituted marcfortines and paraherquamides.
Patent IL-62966-A0 (IL)
Title: Simultaneous production of 2-keto-d-gluconic acid and hydrogen peroxide
IPC: C07C29/10
Filed: 1981-05-26
Abstract: A process is described which is useful as a co-process in combination with a process which employs hydrogen peroxide. The process of the invention plovides a source of hydrogen peroxide along with a useful co-product, that co-product being 2-keto-D-gluconic acid or products derived therefrom. One of the first and second carbons of D-glucose is oxidized enzymatically to produce hydrogen peroxide and an intermediate product. The other of the first and second carbons of the intermediate product is then oxidized enzymatically to produce hydrogen peroxide and 2-keto-D-gluconic acid. In one form of the invention, the intermediate product is D-glucosone; the final product is 2-keto-D-gluconic acid. In the other forms of the invention, the intermediate product is D-glucono-δ-lactone; the final product is a mixture of 2-keto-D-gluconic acid and D-isoascorbic acid.
Patent IL-69900-A0 (IL)
Title: Hyaluronic acid from bacterial culture
IPC: C12P19/04
Filed: 1983-10-04
Abstract: Hyaluronic acid, a polysaccharide, is prepared in high yield from streptococcus bacteria by fermenting the bacteria under anaerobic conditions in a CO2-enriched growth medium, separating the bacteria from the resulting broth and isolating the hyaluronic acid from the remaining constituents of the broth. The bacteria may be grown free of endotoxins by filtering all ingredients through a 10K Millipore TM filter prior to inoculation of the medium and subsequently maintaining pyrogen-free conditions. Separation of the microorganisms from the polysaccharide is facilitated by killing the bacteria with trichloroacetic acid. After removal of the bacterial cells and concentration of the higher molecular weight fermentation products, the hyaluronic acid is isolated and purified by precipitation, resuspension and reprecipitation.
Patent IL-80269-A0 (IL)
Title: Shaped articles of crosslinked polymers and their preparation
IPC: H01B13/14
Filed: 1986-10-09
Abstract: Electrical conductors which are insulated by an inner polymeric layer having little or no cross-linking and high elongation, and an outer polymeric layer having a relatively high level of cross-linking and low elongation. Preferably each of the components comprises a crystalline fluorocarbon polymer, especially an ethylene/tetrafluoroethylene copolymer. Such articles can be prepared by (1) melt-extruding a first polymeric composition which contains little or no cross-linking agent, and a second polymeric composition which contains a greater amount of cross-linking agent, (2) maintaining the two extrudates under conditions such that cross-linking agent migrates from the second to the first composition, and (3) cross-linking both compositions, preferably by radiation.
Patent IL-81317-A0 (IL)
Title: Benzazecine derivatives,their preparation and medicaments containing them
IPC: A61P25/28
Filed: 1987-01-20
Abstract: Benzazecine cpds of the formula (I) and benzoquinoline cpds of the formula (II) are new. R1 and R2 are each independently H or Cl; R3 is H, F, Cl, Br or OCH3; R4 is H, Cl or OCH3, and two or three of R1, R2, R3 and R4 are H; R5 is H, acetyl, propionyl, benzoyl, chloro benzoyl, methoxybenzoyl or phenylacetyl Also in (I) R5 may be a cleavable gp (Z) other than the acyl. - Eighteen cpds (I) including 4-acetyl-9-chloro-1,2,4,5,6,7 - hexahydro-4-benzazecine-3,8-dione and the corresp 4-acetyl-9,11-dichloro, 4-propionyl-11-chloro, 4-(p-methoxybenzoyl) -11-chloro, 9-chloro, 11-chloro-4-phenylacetyl and 4-acetyl-11-bromo cpds are specifically claimed.
Patent IL-82103-A0 (IL)
Title: Cell line producing aids viral antigens without producing infectious virus particles and use of said antigens for detection of aids antibodies in a sample
IPC: G01N33/577
Filed: 1987-04-03
Abstract: Leu-3<-> cells surviving infection with the AIDS retrovirus can be induced with IUdR to express infectious virus. A cellular clone (8E5), isolated by limiting dilution of a mass culture of survivor cells, was found to contain a single, integrated, defective provirus that was constitutively expressed. Although IUdR treatment of 8E5 cells failed to induce infectious virus, cocultivation with Leu-3<+> cells generated the characteristic syncytia associated with acute AIDS retrovirus infection. The single integrated copy of proviral DNA directs the synthesis of all major viral structural proteins except p64 and p34 as monitored by immunoblotting. Diagnostic reagents and kits in accordance with the present invention are also described.
Patent IL-88303-A0 (IL)
Title: Quinoline carboxylic acid derivatives
IPC: A61P31/04
Filed: 1988-11-07
Abstract: Quinolinecarboxylic acid derivative represented by the following general formula (I) and physiologicallyacceptable salt thereof: <CHEM> in which R<1> is hydrogen, alkyl or substituted or unsubstituted phenyl; R<2> is hydrogen or alkyl; and R<3> is hydrogen, halogen or alkoxy. These compounds exhibit antibacterial activity and are useful as remedies for various infectious diseases.
Patent IL-90561-A0 (IL)
Title: Method for making solvent dilution microcarriers
IPC: A23L27/00
Filed: 1989-06-07
Abstract: A method for forming vehicles for encapsulating passenger molecules which have been named solvent dilution microcarriers (SDMC's), and the products of this method are disclosed. The process allows for immediate or delayed formation of the SDMC's following the formation of a shelf stable solution by the dissolution of amphoteric bilayer-forming materials, a solvent, the passenger molecule, addition of aqueous solution, and further addition of solvent. The SDMC's are formed from the shelf stable solution by dilution into an aqueous system, aerosolization, or evaporation and rehydration in situ. Also disclosed are methods of using the SDMC's for treating wounds.
Patent FI-20040907-A0 (FI)
Inventor: MUSTALAHTI JORMA
IPC: B66B21/12
Filed: 2004-06-30
Abstract: A travelator system for conveying a passenger, comprising a main conveyor and a branch conveyor. The main conveyor includes a first plurality of shafts each having a first plurality of belt pulleys disposed side by side thereon. The main conveyor also includes a plurality of mutually parallel endless belt loops which define a moving conveying surface of the main conveyor, each belt loop being passed over a belt pulley on two different shafts. Adjacent belt loops on the same common shaft are passed over different belt pulleys such that a first belt loop is passed over a belt pulley on a previous shaft relative to the common shaft in a transport direction of the main conveyor, while a second belt loop is passed over a belt pulley on a following shaft relative to the common shaft in a transport direction of the main conveyor. The branch conveyor branches off of the main conveyor in a connecting section to allow passengers to enter from the branch conveyor onto the main conveyor and/or to exit from the main conveyor onto the branch conveyor. The branch conveyor is also implemented using shafts, belt pulleys, and belt loops similar to the main conveyor. In the connecting section, the branch conveyor and the main conveyor share at least one common shaft.
Patent IL-103957-A0 (IL)
Title: Method of preparing carboxylic acids or esters thereof by the oxidative cleavage of unsaturated fatty acids or esters thereof
IPC: C07C55/18
Filed: 1992-12-03
Abstract: A method of preparing carboxylic acids or esters thereof by the oxidative cleavage of unsaturated fatty acids or esters thereof is carried out in a two-phase aqueous-organic system in which the organic phase contains the unsaturated fatty acid and/or the esters thereof and the aqueous phase contains hydrogen peroxide. The oxidative cleavage is carried out in the presence of a catalytic system including a catalyst belonging to the group constituted by tungstic and molybdic acids and alkaline salts thereof, and an onium salt which acts as a phase-transfer agent for the catalyst, and has the formula: (R2R3R4R5M)+Y- in which R2, R3, R4 and R5 represent hydrocarbon groups of which at least one must have more than 10 carbon atoms, M is N or P, and Y-is an inorganic anion.
Patent IL-107369-A0 (IL)
Title: Packaging material having at least one line of weakness and process and apparatus for producing it
IPC: B65D75/62
Filed: 1993-10-22
Abstract: A packaging material (21) has at least one line of weakness (23) consisting of weak points (25, 27) arranged at a distance in succession. For an essentially silent destruction of the line of weakness (23), there are zones of of reduced strength being preferably designed to merge continuously into one another as weak points (25, 27). The packaging material preferably consists of cellophane or of biologically degradable plastic foil. The zones of reduced strength can also consist of webs of varying size between perforations of a line of weakness. The invention thereby achieves the destruction of a line of weakness which is staggered in time and which allows an essentially silent opening of packs produced from the packaging material, especially those for articles of hygiene, such as tampons for feminine hygiene. <IMAGE>
Patent IL-110933-A0 (IL)
Title: Tripeptide antithrombotic agents
IPC: A61P7/02
Filed: 1994-09-12
Abstract: This invention provides (1R, 4aR, 8aR)-1,2,3,4,5,6,7,8-perhydroisoquinolin-1-carbonyl-(L)-prolinyl-(L)-a rginine aldehyde and pharmaceutically acceptable salts and solvates thereof, pharmaceutical formulations containing said compounds and methods of their use as thrombin inhibitors, coagulation inhibitors and thromboembolic disorder agents.
Patent IL-111537-A0 (IL)
Title: Crystal modification of (4-cyclopropyl-6-methyl-pyrimidin-2-yl) -phenyl-amine, its preparation and fungicial compositions containing it
IPC: C07D239/42
Filed: 1994-11-07
Abstract: (4-Cyclopropyl-6-methylpyrimidin-2-yl)phenylamine in its crystal modification B and high eutectic purity (at least 98%) with a melting point of between 73 DEG C and 75 DEG C does not have a tendency to crystallise as a fungicidal active compound in crop protection products, which is in contrast to the known modification A. Such compositions are highly storage-stable and retain their original, good suspendability and dispersibility. <IMAGE>
Patent IL-112374-A0 (IL)
Title: Compounds with analgesic and local anaesthetic effect
IPC: A61P29/00
Filed: 1995-01-18
Abstract: New compounds of the formula (A) a process for their preparation and their use in the manufacture of pharmaceutical preparations. The new compounds have both local anaesthetic and analgesic effect.
Patent IL-112403-A0 (IL)
Title: Method for producing a heterologous polypeptide
IPC: A23K1/18
Filed: 1995-01-20
Abstract: A method for preparing polypeptides in bacteria with an alanine rather than a methionine at the N-terminus. The DNA sequence expressed has an alanine codon immediately following from at least one methionine codon, and allows for the expression of polypeptides having the amino acid sequence essentially the same as such naturally occurring eucaryotic protein as various bovine and porcine somatotropin species. In another important embodiment, the invention provides a class of compositions comprising certain valine-containing somatropin species which increase milk production in lactating mammals to a significantly greater extent than otherwise-identical leucine somatotropin species.
Patent IL-115301-A0 (IL)
Title: Process for the manufacture of starch products
IPC: A61P7/00
Filed: 1995-09-14
Abstract: PCT No. PCT/EP95/03806 Sec. 371 Date May 15, 1997 Sec. 102(e) Date May 15, 1997 PCT Filed Sep. 26, 1995 PCT Pub. No. WO96/10042 PCT Pub. Date Apr. 4, 1996Disclosed is the production of starch decomposition products with a narrow molecular weight distribution, based on the treatment of starch or starch derivatives using high-pressure homogenization. The starch decomposition products are obtained in high yields with a narrow molecular weight distribution.
Patent IL-120025-A0 (IL)
Title: Controlled release system and low dose androgens
IPC: B01J13/20
Filed: 1997-01-17
Abstract: Methods of treatment and prevention of estrogen-related diseases, and of fertility control, include low dose (e.g. less than 50 nanomolar serum concentration)administration of certain anabolic steroids, progestins and other substantially non-masculinizing androgenic compounds. Sustained release formulations substantially free of organic solvent, and sustained release formulations for maintaining low serum levels of androgen are disclosed.
Patent IL-122499-A0 (IL)
Title: Patient controlled drug delivery device
IPC: B05B11/00
Filed: 1997-12-07
Abstract: A delivery device for patient-controlled infusion of a medicament (6), the delivery device comprising a reservoir (2) for the medicament (6) and a pump (4) having a predetermined delivery dose which is capable of displacing the medicament from the reservoir (2) and delivering it to a patient, wherein the pump (4) comprises a pumping means (14), a first conduit (10), capable of restricting flow rate, chosen in conjunction with the delivery dose of the pumping means (14) to define a predetermined maximum dosage rate, said conduit (10) connecting the reservoir (2) to a pumping means (14), a one-way valve (18) in fluid communication with the first conduit (10) and the pumping means (14) which permits medicament flow into the pumping means (14) but prevents reverse flow, a controlling means (32), and a second conduit (28) extending from the pumping means and having a distal end (30) through which, the medicament may be released, wherein the controlling means (32), (a) is in fluid communication with the pumping means (12) and the second conduit (28); (b) opens when pressure within the dose chamber (12) exceeds a predetermined minimum opening pressure for the controlling means (32); and, (c) is adapted to prevent the reverse flow of medicament and air into the pumping means.
Patent IL-122939-A0 (IL)
Title: PVC foam compositions
IPC: C08J9/04
Filed: 1998-01-15
Abstract: The density of rigid foamed articles made by the thermal decomposition of a blowing agent in a vinyl chloride polymer is reduced by the use of an organotin halide in combination with a mercaptocarboxylic acid ester or a sulfide of such ester or a mixture of the ester and the sulfide to activate the blowing agent.
Patent IL-136220-A0 (IL)
Title: System and method for electronic inventory
IPC: B65G1/137
Filed: 1998-11-20
Abstract: A system and method for conducting an inventory of tags, wherein each tag (102) is assigned a Tag ID and a manufacture number. Each tag can be attached to an item to take inventory of those items. A tag reader (104) transmits a wake-up signal followed by at least one clock signal. Each tag increments a first tag count in response to the clock signals, and transmits the Tag ID assigned to the tag when the first tag count corresponds to the Tag ID assigned to the tag records the transmitted Tag. When more than one tag transmits simultaneously, the tag stores the Tag ID in order to resolve the contention when the first read cycle (202) is complete. In the second read cycle (206), the tag reader transmits the contended Tag ID followed by at least one clock signal. Each tag that contended for the transmitted Tag ID increments a second tag count in response to the clock signals, and transmits the manufacturer number assigned to the tag when the second tag count corresponds to the manufacturer number assigned to the tag. The tag reader records transmitted Tag IDs, completing the inventory of the tags. <IMAGE>
Patent IL-144775-A0 (IL)
Title: Gels formed by the interaction of poly (aldehyde) with various substances
IPC: A61P17/02
Filed: 2000-01-12
Abstract: The present invention, which addresses the needs of the prior art, provides irreversible, hydrophilic gels which can be incorporated into dressing compositions, dermatologically compatible compositions, wound packings, wound dressings, burn dressings, drug delivery dressings, dry films, cosmetic masks and cosmetic wrap dressings. The gels of the invention include a blend of a hydrophilic poly(aldehyde) and a polymer selected from the group consisting of a poly(amide), a poly(amine) and a poly(alcohol).
Patent IL-148956-A0 (IL)
Title: Air shot mechanism for electronic injection devices
IPC: A61M5/32
Filed: 2000-09-29
Abstract: The present invention relates to an electronic injection device wherein an electronic circuit is designed to work in two alternative modes: an air shot mode and a dose injection mode. When working in the air shot mode a small predetermined air shot dose is pressed out from the ampoule when the injection button is actuated. When working in the injection mode, a dose set by operation of the dose setting means is injected by operation of the injection button. The electronic injection device is normally working in the air shot mode but shifts to work in the dose injection mode when it receives a signal indicating that the dose setting means has been operated. The circuit returns to its air shot mode when receiving a signal indicating that the set dose has been injected. This signal can originate either from a switch indicating that the protection cap is mounted or from a switch indicating that the injection button has been pressed.
Patent IL-150081-A0 (IL)
Title: Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints
IPC: A61K49/20
Filed: 2000-12-06
Abstract: The image obtained by MR imaging of the joint of an animal, including humans, is enhanced by injecting into the joint prior to the scan of an imaging enhancing amount of a nitroxyl functionalized dendrimer containing at least 6 nitroxyl terminal functional groups, e.g, of Formula (I) wherein each R independently is either a nitroxyl group of Formula (II) wherein X is an oxygen atom or two hydrogen atoms, R' is lower alkyl and R'' is H or lower alkyl, or a group of Formula (III) wherein R''' is lower alkyl, or a group of Formula (IV); wherein each alkylene in Formulae (I), (III) and (IV) is a bridging divalent alkylene group of 2-6 carbon atoms with 2-3 carbon atoms in the chain and R is as defined herein, with the proviso that the total number of R groups in the molecule which are nitroxyl groups of Formula (II) is at least 6
Patent IL-152326-A0 (IL)
Title: Pneumovirus ns proteins antagonising the interferon (ifn) response
IPC: C12N15/33
Filed: 2001-04-26
Abstract: The present invention relates to the use of a pneumovirus NS1 protein and/or NS2 protein or a nucleic acid encoding pneumovirus NS1 protein and/or NS2 protein for the preparation of a pharmaceutical formulation for reducing the immune response mediated by interferon (IFN). The invention further relates to recombinant pneumoviruses, in particular respiratory syncytial viruses (RSV), having an increased, reduced, or lacking a resistance to the interferon (IFN) mediated immune response, recombinant viruses having an increased resistance to the interferon (IFN) mediated immune response, and the use of the viruses in pharmaceutical applications, e.g. as vaccines.
Patent IL-154577-A0 (IL)
Title: A system for feeding portions of material to an injection molding machine
IPC: B29C45/76
Filed: 2001-12-27
Abstract: A method for calculating the average weight of each of a plurality of portions of material fed from a hopper. The method is carried out by: first weighing the hopper; after the first weighing, dispensing a given plurality of portions of material; then, in a second weighing step, again weighing the hopper; calculating the difference between the weight of the hopper determined in the first weighing step and the weight of the hopper determined in the second weighing step, the difference constituting the loss of weight of the hopper; and dividing the loss of weight of the hopper by the given plurality of portions. The weighing steps may be performed with a weighing device having a load cell and the given plurality of portions is equal to at least the number calculated by dividing the sensitivity of the load cell by the estimated weight of each fed portion.
Patent IL-159418-A0 (IL)
Title: Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
IPC: A61K31/381
Filed: 2002-07-09
Abstract: The present invention relates to compounds of the general formula (I); or salts thereof, as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
Patent IL-183720-A0 (IL)
Title: Method and apparatus for providing configurable layers and protocols in a communication system
IPC: H04W28/18
Filed: 2007-06-06
Abstract: The layers and protocols of an air interface layering architecture are designed to be modular and can be modified and upgraded to support new features, perform complex tasks, and implement additional functionality. Prior to commencement of data communication between a first entity (e.g., an access terminal) and a second entity (e.g., a radio network), a set of layers and/or protocols is selected for negotiation. For each selected layer and protocol (i.e., each attribute), a list of attribute values considered acceptable to the first entity is determined. The selected attributes and their associated attribute values are sent from the first entity and, in response, a list of processed attributes and their associated lists of processed attribute values arc received. Each list of processed attribute values includes attribute values considered acceptable to the second entity. The layers and protocols in the first entity are then configured in accordance with the received list of processed attributes and their associated processed attribute values. Other features related to configurable layers and protocols are also provided.